Qualikems Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 03-12-2024
- Paid Up Capital ₹ 4.20 M
as on 03-12-2024
- Company Age 16 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.75 Cr
as on 03-12-2024
- Satisfied Charges ₹ 1.27 Cr
as on 03-12-2024
About Qualikems Lifesciences
The Corporate was formerly known as Qualikems Fine Chem Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.20 M.
The company currently has active open charges totaling ₹2.75 Cr. The company has closed loans amounting to ₹1.27 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ashok Sahni, Sushant Sahni, and Satish Sahni serve as directors at the Company.
- CIN/LLPIN
U24100GJ2008PTC120822
- Company No.
184256
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Oct 2008
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Qualikems Lifesciences Private Limited offer?
Qualikems Lifesciences Private Limited offers a wide range of products and services, including Chemical Reagents & Catalysts, Ammonium Compound, Inorganic Salts, Bird Food, Poultry & Animal Food, Animal Feed Supplement, Industrial Chemicals & Supplies, Plating Chemicals, Metal & Metal Made Products, Nano Powder, Flavours & Aromatics.
Who are the key members and board of directors at Qualikems Lifesciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashok Sahni  | Director | 15-Oct-2008 | Current |
| Sushant Sahni | Director | 15-Oct-2008 | Current |
| Satish Sahni | Director | 27-Feb-2024 | Current |
Financial Performance of Qualikems Lifesciences.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Qualikems Lifesciences?
Unlock access to Qualikems Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 04 Oct 2024 | ₹2.00 Cr | Open |
Others Creation Date: 25 Aug 2023 | ₹7.50 M | Open |
Bank Of Baroda Creation Date: 19 Feb 2011 | ₹1.20 Cr | Satisfied |
How Many Employees Work at Qualikems Lifesciences?
Unlock and access historical data on people associated with Qualikems Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Qualikems Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Qualikems Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
